Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment... Show more
Plexus Corp. is a publicly traded electronics manufacturing services provider that helps other companies bring complex products to market. Rather than selling finished goods under its own name, Plexus designs, engineers, and manufactures products on behalf of customers in industries where precision, quality, and regulatory compliance are critical. Investors follow PLXS because its performance offers a window into demand trends across healthcare technology, industrial automation, and defense supply chains.
Plexus was founded in 1979 and is headquartered in Neenah, Wisconsin. The company has grown into a global operation with roughly 20,000 employees and manufacturing facilities spread across the Americas, Asia-Pacific, and EMEA. Its shares trade on the Nasdaq under the ticker PLXS.
Plexus operates as an EMS provider, which means it offers design, supply chain, new product introduction (NPI), manufacturing, and aftermarket "sustaining" services across the full lifecycle of a product. This business model lets customers outsource the engineering and production of complex hardware while retaining ownership of their own brands and intellectual property.
The company organizes its business into three reportable geographic segments. The AMER segment covers the Americas, APAC covers Asia-Pacific, and EMEA covers Europe, the Middle East, and Africa. Its end markets include Healthcare/Life Sciences (such as medical devices and diagnostic equipment), Industrial (including industrial automation and semiconductor capital equipment), and Aerospace/Defense, which focuses on mission-critical systems with stringent regulatory oversight.
Plexus competes in a broad EMS market alongside other contract manufacturers that produce electronics for original equipment manufacturers (OEMs). What differentiates Plexus is its focus on relatively complex, regulated products rather than high-volume commodity electronics. By targeting demanding sectors, the company aims to build deeper, longer-lasting customer relationships that are harder for competitors to displace.
The company's financial profile reflects this positioning. In fiscal 2024, Plexus reported net sales of approximately $3.96 billion, with the Healthcare/Life Sciences and Industrial sectors each contributing a large share of revenue and Aerospace/Defense growing strongly year over year. In fiscal 2025, net sales rose to approximately $4.03 billion.
Investors monitor PLXS for several reasons. First, its diversified end-market exposure spans healthcare, industrial, and defense — sectors with distinct demand drivers that can offset weakness in any single area. Aerospace/Defense, for example, has been a growth area supported by resilient government and commercial demand.
Second, Plexus's emphasis on complex, regulated products can support stickier customer relationships and more stable program revenue over time. Third, the company's global manufacturing footprint gives it supply chain flexibility and access to customers across major regions. Investors also watch its ability to win new programs and convert them into sustained production revenue, since new program wins are a leading indicator of future sales.
Investing in Plexus carries meaningful risks. The company has a concentrated customer base, with its top customers historically accounting for a substantial portion of net sales. Losing a major account or a large program can materially affect revenue. The EMS industry is also competitive, and customer demand is sensitive to macroeconomic conditions, inventory cycles, and component pricing.
Plexus's operations are exposed to geopolitical and supply chain risks, particularly given its significant manufacturing presence in Asia. Shifts in trade policy, tariffs, or regional disruptions can raise costs or force production changes. Additionally, demand in sectors such as Healthcare/Life Sciences and Industrial has at times been volatile, and the company has periodically undertaken restructuring actions to manage costs. These factors make Plexus's financial results sensitive to forces beyond its direct control.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps traders and investors identify opportunities using technical indicators, fundamentals, volatility, trends, AI-generated signals, industries, price patterns, and customizable filters. Users can efficiently screen thousands of stocks and ETFs to surface ideas that match their own investment strategies. Explore the AI Screener to refine your research workflow.
Plexus Corp. is a distinctive player in the electronics manufacturing services industry, pairing global scale with a focus on complex, regulated products in healthcare, industrial, and aerospace/defense markets. Its business model thrives on long-term OEM partnerships and full-lifecycle support, which has helped it build a meaningful market position. For investors, PLXS offers exposure to multiple technology-driven end markets, though that exposure comes with customer concentration, competitive, and supply chain risks worth understanding.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of electronic manufacturing services
Industry ElectronicComponents